Integrative Oncology: Combining Cancer Treatments & Lifestyle
Featuring: Mark Taylor, Gabriele Gavazzi
In short
Mark Taylor and Gabriele Gavazzi, researchers who have tracked thousands of integrative oncology patients, share how to combine conventional cancer treatments with evidence-based complementary therapies. They focus on what the clinical research actually supports — and where common beliefs, like the power of diet alone, outrun the evidence. Their work is especially relevant for people with advanced adenocarcinomas who want to go beyond standard care without getting misled.
- •Prioritize complementary treatments that have human clinical trial evidence — be skeptical of approaches supported only by lab or animal studies, or by marketing claims alone.
- •Exercise is the lifestyle change with the strongest support; be cautious about replacing standard treatment with diet, since the evidence for diet is more limited than widely believed.
- •For pancreatic cancer specifically, maintaining urine pH above 7.5 and managing blood glucose during chemotherapy are two approaches tied to meaningfully better outcomes in clinical data.
- •Ask your doctor about lower-dose combinations of treatments — the goal is to maintain effectiveness while reducing side effects, not just piling on more.
Watch on Cancer Patient Lab YouTube
Ask anything about this — free, no signup
Instant answers grounded in real guidelines, not the internet.
“What became key in our research is ultimately that the perfect oncology treatment is a combination of treatments. ” – Mark Taylor “My initial objective was to understand the effectiveness of a lot of the stuff that's not well researched. In general, I found very, very few things that worked effectively that were not studied in clinical research. That was my finding.
” – Mark Taylor “There are a lot of things in lifestyle that are very complicated, but some are very simple. Exercise is the most obvious one to start on. It works on so many different levels. We talk about different diets, but in general, I'm a bit suspicious of diets, because the studies aren't as grand as people expect them to be.
I have a lot of patients who come to me who have shunned the standard of care and believe that a diet is going to fix them. The huge category of people like that because they've got distrust in the pharma world. Very, very few of them do well. There's a misperception of the benefits of diet.
Meeting Summary
Cancer patients with a cancer diagnosis are confused about what to do alongside the standard of care to improve their outcomes. Many cancers have no good treatments and most treatments work for a while until they don't. There is a lack of trustworthy, unbiased sources of information on cancer treatments outside the standard of care, including on costs and effectiveness.
Mark Taylor and Gabriele Gavazzi are uniquely qualified to lead a discussion on what to do in this relatively uncharted territory. Mark's own experimentation with integrative oncology solutions, such as cancer vaccines, anti-cancer IVs, mRNA gene silencers, cell therapies, hyperthermia, and Coley's toxins.
He then moved into psycho-spiritual approaches, working with top healers such as Gabor Mate, Sholin monks, Qi Gong masters, and numerous shamans from Brazil and Peru. 2. outcomes following patients in Mark's Facebook group of over 6000 patients. Working with some of the top experimental oncologists in the world. Research that keeps track of the research pool into integrative oncology in real time.
1", which includes all the clinical studies patients can use to improve their outcomes. It also includes a concept called the "endgame strategy", which is their opinion on the optimal way to treat stage 4 adenocarcinomas (one of the most common types of cancer occurring in the lungs, breast, colon, pancreas, and prostate) using the latest science.
What principles should guide your cancer treatment selections, especially for complementary treatments?
•Be evidence-driven and open to innovative approaches while maintaining scientific rigor
•Prioritize treatments with human clinical research evidence (not cell lines or animal models)
•Personalize your treatment selections based on your unique factors, like your financial resources, personal willingness to travel or take risks, and overall health and age
•Look for synergistic treatment combinations; consider low-dose combinations of treatments
•Use testing to focus and personalize treatments
•Focus on reducing side effects while maintaining treatment effectiveness
•Understand the specific biological mechanisms of potential treatments
•Be skeptical of marketing claims without solid scientific backing
•Continuously update and adapt your treatment approach based on the latest research How can you integrate lifestyle changes, such as exercise and nutrition, into your treatment recommendations?
•Exercise is considered the most significant lifestyle intervention, working on multiple levels to potentially improve cancer outcomes.
•While you should consider your diet, you should be cautious about overstating its benefits, since diet studies aren't as conclusive as many believe.
•You should be careful about completely replacing standard care with lifestyle interventions.
•You need to consider personalized complementary treatments that are relevant for your cancer situation, rather than adopting a one-size-fits-all approach. What are examples of personalized complementary treatments that are relevant for particular cancer situations?
•pH modulation: For pancreatic cancer patients, maintaining a urine pH of 7.5 and above was associated with significantly longer survival (29.9 months vs. 8 months for those with pH below 6.5).
•Blood sugar management : For panc pancreatic cancer patients undergoing chemotherapy, managing blood glucose levels can potentially sensitize cancer cells to chemotherapy, with some studies showing remarkable responses.
•Fasting: Between chemotherapy treatments, fasting can help slow cancer progression and protect the body.
•Dosage optimization : Using lower, more targeted doses of chemotherapy, TKIs, and other treatments to reduce side effects while maintaining effectiveness. How can you learn more about navigating integrative cancer treatment?
•Explore the Hacking Cancer Research Portal
•Join the Patient Led Oncology Facebook group
•Request a consultation with Mark Taylor (which includes access to the Hacking Cancer Research Portal)
•See previous discussions we have had on complementary cancer treatments, such as:
•
•"A Patient’s View on Nutrition, Supplements, Integrative Oncology, and Complementary Therapies"
••
•The information and opinions expressed on this website or platform, or during discussions and presentations (both verbal and written) are not intended as health care recommendations or medical advice by Cancer Patient Lab, its principals, presenters, participants, or representatives for any medical treatment, product, or course of action. You should always consult a doctor about your specific situation before pursuing any health care program, treatment, product or other course of action that might affect your health. Meeting Notes KEYWORDS Cancer patient lab, integrative oncology, Mark Taylor, Gabriele Gavazzi, research portal, clinical research, patient-led oncology, cancer treatments, immunotherapy, metabolic treatments, AI tools, patient navigation, clinical trials, oncology research, patient coaching. SPEAKERS Mark Taylor (74%), Brad Power (22%), Gitte Pedersen (2%), Eric Dishman (1%), Len Sierra (1%) CHAT CONTRIBUTORS Allen Morris, Gitte Pedersen, Chad Magnussen, Helen, Raj Aji, Eric Dishman, Gabriele Gavazzi, Dennis SUMMARY Mark Taylor discussed the Patient Led Oncology research on integrative oncology, highlighting the Hacking Cancer Research Portal, which aggregates clinical research and provides tools for patients to navigate treatment options. Mark shared his personal experience with pancreatic cancer and the importance of evidence-b treatments. The portal, available in soft launch, offers a comprehensive database of treatments, clinical trials, and research articles, aiming to bridge the gap between standard care and experimental treatments. They emphasized the need for patients to be informed and proactive in their care, leveraging AI and personalized guidance to improve outcomes. OUTLINE Introductions
•Mark Taylor shared insights on integrative oncology.
•He shared his personal story of getting an early pancreatic cancer diagnosis and his research project on global clinics and treatments.
•Mark Taylor introduced the Hacking Cancer Research Portal, an online tool to help patients quickly access the latest research.
•The portal is patient-led, focusing on integrative oncology and following patients through experimental doctors.
•They aggregate clinical research.
•There is an increasing gap between standard of care and experimental treatments.
•The team includes Mark, Gabriele, and two research scientists, Dr. Jihan and Dr. Sahil, with a focus on keeping doctors up-to-date with the latest research. Problems Addressed by the Hacking Cancer Research Portal
•Mark outlined the eight problems the portal aims to solve, including patient overwhelm, confusion about oncologist advice, and lack of transparency in integrative oncology.
•The portal helps patients read clinical studies, judge good clinical trials, and access treatments and tests.
•The portal provides sources for research, service providers, and a framework for combining treatments.
•The portal aims to provide trusted information and a roadmap for patients and doctors, with a focus on end-stage adenocarcinomas. Guiding Principles and Fundamentals of the Portal
•The guiding principles of the portal include catering to different patient resources and needs.
•The portal includes fundamentals like pH modulation, which showed significant outcomes in pancreatic cancer patients.
•The portal provides tools to help patients access healers and psychedelics.
•The portal includes treatment strategies, such as the Chow principle, which suggests reduced doses of multiple drugs can be as effective as full doses of a single drug. Treatment Strategies and Immunotherapy
•A key concept is that core, synergistic treatments are combined with standard of care and with immunotherapy.
•The portal includes a circle of immunotherapy, breaking down the aspects needed for an immune response.
•The portal provides information on high mutational burden and the effectiveness of vaccines in clinical trials.
•The portal aims to help patients understand and navigate the complex world of integrative oncology treatments. Practicalities and Future Plans
•The portal will be available for a soft launch, with a free tier and paid tiers for advanced patients and doctors.
•Mark plans to hold group coaching sessions and provide access to the portal for a month during coaching sessions.
•The portal will be updated in real-time, with new research added regularly.
•There is potential for a chatbot interface and a questionnaire to guide patients through the process. Collaboration
•Brad Power suggested a potential collaboration with Cancer Patient Lab, including a chatbot interface and AI guides.
•Mark and Brad discussed the importance of lifestyle changes, such as exercise and nutrition, in cancer treatment.
•Mark explained the challenges of using AI tools like ChatGPT and the need for careful prompting to ensure accurate information.
Full transcript
Brad Power This is the Cancer Patient Lab. We're happy to have you all here today. We're honored to have Mark Taylor and Gabriele Gavazzi here to tell us about the latest insights they've been gathering. You may not know or may recall for some of you that Mark and Gabriele were on a session with us before.
Mark has an incredible personal story of getting an early pancreatic cancer diagnosis and then pursuing a global search for clinics and treatments that he might consider. He turned that into a research project where he asked patients who went to clinics globally, what treatment they got and what the results they got were.
Now he has one of the best databases I'm aware of, of all of these integrative oncology clinics that are in various places all around the world. So a very good resource for that. Gabriele is his right hand man, who, if you ask him a question about anything, you get a very long answer with 10 citations.
Gabriele just does incredible research, and together, they put that kind of research that they've done into what is evidence-based, evidence-directed, best practices in care, which I'm sure they'll tell you more about. I rely on Mark and Gabriele to make sense out of the area of integrative oncology, which has some alternative approaches that are sometimes questionable, but seem to have some evidence. How do you make sense of it all?
When I want to make sense of it all, I go to Mark and Gabriele, so just a personal endorsement before we get started. We have a few housekeeping things we always say at the beginning. One is, this is for information purposes only. This is not medical advice. We try to bring information to our patients and caregivers that they can take to their medical team.
We are a 501(c)(3) nonprofit, and we depend on the kindness of donations to bring this webinar series to you, and would appreciate any donations you might make, which you can do on our website, where there's a Donate button, and it's very easy. Mark Taylor 2:30 We are here to announce that it's been many years of research.
It was an answer to the problem I had when I had a cancer scare with CTCs in that when you enter the alternative world, you don't know what to trust. I see it increasingly with patients. It's an online portal to help a patient get up to speed quickly with the latest research. We've created tools to help with that. We're introducing what we're calling the Hacking Cancer research portal. And my organization is patient led oncology.
We are a research organization. We research integrative oncology, so everything your oncologist is not giving you through four lenses. I have my own experiences, and I could write a book about that. We also follow patients through our group and through patients I coach.
Generally patients who are going to the top experimental doctors in the world come to me, and I get to find out what the experimental doctors are doing and reverse engineer their research. Increasingly, we're selling our research to doctors. So we're getting the circular information with those doctors, feeding information into them and understanding how their patients are doing. And then ultimately, we've become an aggregator of clinical research.
Very rarely do we see approaches working that have not been studied in clinical (phase I/II or mice) research. Most of the stuff we do these days is to read clinical papers. We have filters on all the research databases. We're looking at about 30 to 50 research articles a day.
Part of my thought process behind creating this is that the problem between the standard of care oncologist and what's going to be available in the experimental space is going to increasingly get more sophisticated. Medical knowledge is doubling every three months, and still, the standard of care model takes 18 to – in some cases – 40 years to get a drug into the standard of care.
What we're starting to see – and I think it will only accelerate – is a bigger and bigger gap between what the standard of care is offering and what you can get with a doctor who's paying attention to the latest research.
Want to learn more about your specific case?
Upload your medical records and ask Navis questions tailored to your diagnosis.